Explore more publications!
Guinea Bissau Health Bulletin
Got News to Share?

Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 3, 2025

Elevar Therapeutics Announces Publication of CARES-310 Study Final Analysis in The Lancet Oncology
December 3, 2025

Elevar Therapeutics Announces Publication of CARES-310 Study Final Analysis in The Lancet Oncology

Indeterminate GlobeNewswire
BetaGlue Therapeutics erweitert klinische Studie in Italien nach Genehmigung vom italienischen Gesundheitsministerium zur Durchführung einer klinischen Studie bei nicht resezierbarem, lokal fortgeschrittenem Bauchspeicheldrüsenkrebs (uLA-PDAC)
December 3, 2025

BetaGlue Therapeutics erweitert klinische Studie in Italien nach Genehmigung vom italienischen Gesundheitsministerium zur Durchführung einer klinischen Studie bei nicht resezierbarem, lokal fortgeschrittenem Bauchspeicheldrüsenkrebs (uLA-PDAC)

Indeterminate GlobeNewswire
BetaGlue Therapeutics étend son essai clinique en Italie après avoir obtenu l’autorisation du ministère de la Santé italien pour mener son étude clinique sur le cancer du pancréas localement avancé non résécable (uLA-PDAC)
December 3, 2025

BetaGlue Therapeutics étend son essai clinique en Italie après avoir obtenu l’autorisation du ministère de la Santé italien pour mener son étude clinique sur le cancer du pancréas localement avancé non résécable (uLA-PDAC)

Indeterminate GlobeNewswire
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
December 3, 2025

Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product

Indeterminate GlobeNewswire
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum
December 3, 2025

Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum

Indeterminate GlobeNewswire
Wesley Pharmaceuticals Unveils First Product, Zinc Sulfate, Revolutionizing Wellness Solutions
December 3, 2025

Wesley Pharmaceuticals Unveils First Product, Zinc Sulfate, Revolutionizing Wellness Solutions

Indeterminate GlobeNewswire
Brevard Health Alliance Improves Hypertension Control with RPM Program Utilizing Rimidi's Platform and Connected Devices
December 3, 2025

Brevard Health Alliance Improves Hypertension Control with RPM Program Utilizing Rimidi's Platform and Connected Devices

Indeterminate GlobeNewswire
Aeroflow Urology Donates $30,000 to Support Family-Centered Care
December 3, 2025

Aeroflow Urology Donates $30,000 to Support Family-Centered Care

Indeterminate GlobeNewswire
Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants Advancing Treatments Across Multiple Neuromuscular Diseases
December 3, 2025

Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants Advancing Treatments Across Multiple Neuromuscular Diseases

Indeterminate GlobeNewswire
Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing
December 3, 2025

Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing

Indeterminate GlobeNewswire
Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares
December 3, 2025

Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares

Indeterminate GlobeNewswire
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
December 3, 2025

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™

Indeterminate GlobeNewswire
Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology
December 3, 2025

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Indeterminate GlobeNewswire
Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia
December 3, 2025

Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia

Indeterminate GlobeNewswire
Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting
December 3, 2025

Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
December 3, 2025

Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space

Indeterminate GlobeNewswire
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in…
December 3, 2025

Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in…

Indeterminate GlobeNewswire
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
December 3, 2025

Biodesix to Present New Data at Two Major Upcoming Scientific Meetings

Indeterminate GlobeNewswire
NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.
December 3, 2025

NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.

Indeterminate GlobeNewswire
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 3, 2025

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions